Which hedge funds own ESPREUR? ESPERION THERAPEUTICS INC NE, Q2 2026 13F holders
32 tracked hedge funds disclosed a position in ESPREUR (ESPERION THERAPEUTICS INC NE) in their Q2 2026 13F filings, worth $249.1m in total. The largest holder by portfolio weight is Trium Capital LLP at 22.2% of its book. 21 opened a new position this quarter: Trium Capital LLP, Beryl Capital Management LLC, PSquared Asset Management AG, Chicago Capital Management, LLC. 20 exited: Two Seas Capital LP, Pavaki Capital Management LLC, Orbimed Advisors LLC.
- 32
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 21
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 20
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $210m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $104m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $249m
- Combined value Sum of the holders' reported positions in the security.
- 2.6%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Two Seas Capital LP | 1.4% | $31.2m |
| Pavaki Capital Management LLC | 0.8% | $1.1m |
| Orbimed Advisors LLC | 0.6% | $29.0m |
| Armistice Capital, LLC | 0.4% | $10.8m |
| Eversept Partners, LP | 0.3% | $4.8m |
| ACT Capital Management, LLC | 0.1% | $130k |
| Scientech Research LLC | 0.08% | $90.4k |
| Diametric Capital, LP | 0.07% | $282k |
| Oxford Asset Management LLP | 0.03% | $74.9k |
| EntryPoint Capital, LLC | 0.02% | $64.4k |
| D. E. Shaw & Co., Inc. | 0.01% | $17.9m |
| Point72 Asset Management, L.P. | 0.01% | $4.6m |
| Graham Capital Management, L.P. | 0.01% | $195k |
| Squarepoint Ops LLC | 0.0% | $1.9m |
| ADAR1 Capital Management, LLC | 0.0% | $58.6k |
| Brevan Howard Capital Management LP | 0.0% | $126k |
| Qube Research & Technologies Ltd | 0.0% | $570k |
| AQR Capital Management LLC | 0.0% | $863k |
| Hudson Bay Capital Management LP | 0.0% | $32.5k |
| Walleye Capital LLC | 0.0% | $8.3k |
Ownership over time
Who discovered ESPREUR first? Beta
The run: Q2 2025 → Q4 2025, +276%
| Two Seas Capital LP high conviction | Q3 2025 | 1.0% | +2.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.